A phase II study to evaluate the safety and efficacy of IMM-101 in combination with checkpoint inhibitors in patients with advanced melanoma: Final results of the IMM101-015 trial
Fusi, A. Gupta, A. Lorigan, Paul C Smith, P. L. Bowles, M.
Fusi, A.
Gupta, A.
Lorigan, Paul C
Smith, P. L.
Bowles, M.
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Fusi A, Gupta A, Lorigan P, Smith PL, Bowles M. A phase II study to evaluate the safety and efficacy of IMM-101 in combination with checkpoint inhibitors in patients with advanced melanoma: Final results of the IMM101-015 trial. Journal of Clinical Oncology. 2022 Jun;40(16). PubMed PMID: WOS:000863680302373.